Indian Pharma Network – Buy prescriptions drugs

Myozyme (Alglucosidase alfa)

  • Medicine Name: Myozyme
  • API: Alglucosidase alfa
  • Dosage Form & Strength: Lyophilized powder for solution for intravenous infusion: 5 mg/mL
  • Manufactured By: Genzyme Corporation

Medical Uses

Myozyme (alglucosidase alfa) is a lysosomal glycogen-specific enzyme indicated for use in patients with Pompe disease (GAA deficiency). This therapeutic drug has been shown to improve ventilator-free survival in patients with infantile-onset Pompe disease as compared to an untreated historical control, whereas use of this drug in patients with other forms of Pompe disease has not been adequately studied to assure safety and efficacy.

Recommended Dosage:
The recommended dosage regimen of Alglucosidase alfa is 20 mg/kg body weight administered every 2 weeks as an intravenous (IV) infusion.

Warning & Precautions

  • Serious allergic reactions, including anaphylaxis, may occur during or after infusion. Signs and symptoms include swelling, difficulty breathing, rashes, or chest pain. Always monitor patients throughout infusion and have emergency treatment ready. Stop treatment quickly if a serious allergic response occurs.
  • Certain patients might experience responses that attack the immune system’s cells. These responses may lead to inflammation of organs such as the skin or kidneys. If any symptoms that you consider unusual arise, please see your physician without delay. It is highly advisable to check the immune response to treatment from time to time.
  • Alglucosidase alfa can be responsible for causing breathing or heart complications during infusion, particularly in those with underlying heart or lung disease. Monitor closely throughout and after infusion. Use caution and consider pre-treatment testing for high-risk individuals to reduce complications.
  • Common infusion-related reactions include nausea, fever, chills, headache, and low blood pressure. These usually arise during or shortly after administration. Slowing the infusion rate or giving pre-medicine may help reduce the signs and symptoms. Stop infusion if serious reactions occur and provide proper supportive care.
  • Regular lab tests must be performed to check kidney function, liver enzymes, and immune response. Monitoring helps detect early side effects or allergic reactions. Blood tests before and after treatment ensure safety and allow timely dose adjustments when necessary.
  • There is limited information on the use of Alglucosidase alfa during pregnancy. It should only be used if the potential benefit justifies the risk to the unborn baby. Pregnant women must consult their healthcare provider (HCP) before starting or continuing treatment.
  • It is not known if this therapeutic drug passes into human breast milk. A breastfeeding mother should discuss with her clinician about the risks and benefits. Based on the child’s health and the mother’s requirement for treatment, breastfeeding may need to be paused.

Documentation & Availability

What documents are required to import MYOZYME to India?

MYOZYME (alglucosidase alfa) injections can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

  • A valid prescription from a qualified doctor.
  • Patients diagnostic reports
  • Patient ID proof (issued by the government of India)
How does the order get confirmed?

The order will be confirmed only after the receipt of:

  • A valid prescription from the Doctor
  • Import permit if applicable
Is MYOZYME available in India?

MYOZYME (alglucosidase alfa injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

  • On availability of Myozyme in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
  • On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  • Medicine Price.
  • Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  • Ensuring 100% transparency.

MYOZYME can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of MYOZYME (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Myozyme 5 mg/mL injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Sourcing & Delivery

Indian Pharma Network can source MYOZYME (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

FAQ

What is the Generic Name for the trade name drug Myozyme®?

Alglucosidase alfa is the Generic Name for the trade name drug Myozyme®.

What is the Manufacturer's Name of Myozyme®?

Myozyme® is manufactured by Genzyme Corporation.

Is Myozyme® approved by the FDA?

Yes, Myozyme® is approved by the FDA. Date of first approval: April 28, 2006.

What is the dosage and form of Myozyme® supplied?

Myozyme is supplied in lyophilized powder for solution for intravenous infusion: 5 mg/mL for intravenous (IV) infusion.

What are the most common side effects of Myozyme® 5 mg/mL injection? 

The most common side effects of Myozyme® are pneumonia, respiratory distress, catheter-related infection, respiratory failure, respiratory syncytial virus infection, fever, and gastroenteritis.

How much does Myozyme® 5 mg/mL injection cost in India?

Myozyme® is not yet approved in India. However, patients in India can legally access it through the provision Named Patient Program (NPP). Prices of Myozyme injections may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Myozyme 5 mg/mL cost in India, please call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Myozyme® 5 mg/mL injections be available in SAARC countries? 

Apart from Gulf countries, Myozyme® can be accessed through import provisions like Named Patient Import in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Myozyme® injection in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Myozyme® 5 mg/mL injection online in India?

Yes, one can buy Myozyme 5 mg/mL online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of this therapeutic drug through legal channels. 

What are the storage conditions of Myozyme® 5 mg/mL injections?

Store this therapeutic drug under refrigeration between 2°C to 8°C (36°F to 46°F). Do not use it after the expiration date mentioned on the vial. 

Contact Patient Support

If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.

Product Enquiry